logo

For the Inventor, By the Inventor

San Antonio, TX, United States of America

Celonova Biosciences, Inc.


USPTO Granted Patents = 16

% Expired Patents = 43.8



Trademarks = 3

Forward Citations = 69

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Michael Lee (6 out of 40 patents)

silverMedal Richard L Klein (4 out of 11 patents)

bronzeMedal Ulf Fritz (3 out of 10 patents)

4.  Riley King (3 out of 3 patents)

5.  John Birtles (3 out of 3 patents)

6.  John Koos (3 out of 3 patents)

7.  Olaf Fritz (2 out of 9 patents)

8.  Kent C B Stalker (2 out of 45 patents)

9.  James Clayton Peacock, Iii (2 out of 49 patents)

10.  Ronald Wojcik (2 out of 5 patents)

11.  Thomas A Gordy (2 out of 7 patents)

12.  Stuart Earl Kari (2 out of 14 patents)

13.  Mark C Bates (2 out of 36 patents)

14.  Jacques Blümmel (2 out of 4 patents)

15.  Alexander Küller (2 out of 5 patents)


16 patents:

1. 10881540 - Implantable and lumen-supporting stents and related methods of manufacture and use (2021-01-05),
2. 10327926 - Implantable and lumen-supporting stents and related methods of manufacture and use (2019-06-25),
3. 10285968 - Drug eluting expandable devices (2019-05-14),
4. 9949944 - Drug eluting expandable devices (2018-04-24),
5. 9717608 - Expandable devices (2017-08-01),
6. 9445927 - Implantable and lumen-supporting stents and related methods of manufacture and use (2016-09-20),
7. 9358139 - Expandable devices (2016-06-07),
8. 9114162 - Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same (2015-08-25),
9. 9114125 - Drug eluting expandable devices (2015-08-25),
10. 9107850 - Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same (2015-08-18),
11. 9080146 - Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface (2015-07-14),
12. 8541014 - Gamma-tocopherol therapy for restenosis prevention (2013-09-24),
13. 8101275 - Device based on nitinol, a process for its production, and its use (2012-01-24),
14. 8101199 - Des-methyl-tocopherol therapy for restenosis prevention (2012-01-24),
15. 8097269 - Bioactive material delivery systems comprising sol-gel compositions (2012-01-17),
Company Overview
Celonova Biosciences, Inc. is a biotechnology company based in San Antonio, Texas, specializing in the development of innovative medical devices and therapeutic solutions. The company focuses on advancing technologies that enhance patient care, particularly in the fields of interventional medicine and oncology. Celonova's research emphasizes the integration of cutting-edge materials and engineering to create products that improve treatment outcomes and safety for patients undergoing various medical procedures.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Celonova Biosciences, Inc. USPTO Patent Assignee Logo
16 Patents

#42 in San Antonio, TX

#1,214 in Texas

#19,907 in US

#37,788 in the World

San Antonio, TX (US)
San Antonio, TX, United States of America

Celonova Biosciences, Inc.

Forward Citations = 69

26 inventors:

goldMedal Michael Lee (6 out of 40 patents)

silverMedal Richard L Klein (4 out of 11 patents)

bronzeMedal Ulf Fritz (3 out of 10 patents)

4.  Riley King (3 out of 3 patents)

5.  John Birtles (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Celonova Biosciences, Inc.. Retrieved from https://idiyas.com/company/celonova-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…